StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$227.97−4.26 (-1.83%)

Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –

Danaher Life Sciences — Price Impact (10-K) by Year

Life Sciences — Price Impact (10-K) (%)

Danaher Life Sciences — Price Impact (10-K): 0.5% in FY2025, down 0.5 pts from a year earlier.

Latest, FY2025
0.5%
Period ended Dec 31, 2025
Change on a year earlier
-0.5 pts
1.0% in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below

Where the FY2025 figure comes from

“Price increases in the segment contributed 0.5% to the change in sales on a year-over-year basis during 2025 as compared with 2024 and are reflected as a component of core sales above.”

Source: Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗

Reported in Danaher SEC Form 10-K (Item 7 MD&A — Life Sciences).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLife Sciences — Price Impact (10-K) (%)Year on yearSource
FY2025Dec 31, 20250.5%-0.5 ptsDanaher SEC 10-K (FY2025, filed 2026-02-24) ↗
FY2024Dec 31, 20241.0%-3.0 ptsDanaher SEC 10-K (FY2024, filed 2025-02-20) ↗
FY2023Dec 31, 20234.0%-1.0 ptsDanaher SEC 10-K (FY2023, filed 2024-02-21) ↗
FY2022Dec 31, 20225.0%+3.0 ptsDanaher SEC 10-K (FY2022, filed 2023-02-22) ↗
FY2021Dec 31, 20212.0%+1.0 ptsDanaher SEC 10-K (FY2021, filed 2022-02-23) ↗
FY2020Dec 31, 20201.0%–Danaher SEC 10-K (FY2020, filed 2021-02-25) ↗

Cite this data

StockData. (2026). Danaher Life Sciences — Price Impact (10-K) (%), annual FY2020–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/mda-price-impact-lifesci

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.